Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces First Subject Dosed in Phase 1 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) 2022-08-18 08:00
Picarro Introduces the First Automated Solution for Continuous Ethylene Oxide Monitoring 2022-08-17 22:08
JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS 2022-08-17 14:30
Increased Precision and Safety in Spinal Tap with PASS - An Ultrasound-Guided Lumbar Puncture Procedure 2022-08-17 10:00
Global Cord Blood Corporation Files Annual Report on Form 20-F 2022-08-17 04:16
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML 2022-08-17 04:05
Vision Loss Rehabilitation Canada brings AI-driven diabetic eye screening to rural and Indigenous communities 2022-08-16 20:00
Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel 2022-08-16 19:30
Profitable growth continues: Exyte with remarkable 6M/2022 results and uplifted year-end outlook 2022-08-16 16:24
ExoCoBio's First Global Regenerative Aesthetic Exosome Summit 2022-08-16 15:00
Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics 2022-08-16 14:48
ICP DAS - BMP will attend MEDICAL MANUFACTURING ASIA 2022 in Singapore 2022-08-16 10:15
Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia 2022-08-16 08:30
Gannex Announces First Subject Dosed in the U.S. Drug-Drug Interaction Study of FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis 2022-08-16 08:10
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories 2022-08-16 07:15
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud 2022-08-12 20:00
Seegene reports H1 2022 financial results 2022-08-12 19:00
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-11 20:08
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan 2022-08-11 08:00
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine 2022-08-10 16:06
1 128 129 130 131 132 490